Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

JMP Securities Reiterates Market Outperform on argenx, Maintains $471 Price Target

Author: Benzinga Newsdesk | March 22, 2024 01:08pm
JMP Securities analyst Jason Butler reiterates argenx (NASDAQ:ARGX) with a Market Outperform and maintains $471 price target.

Posted In: ARGX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist